Sena K. Biswas
Director Ejecutivo en VIMAC Ventures LLC .
Perfil
Sena K.
Biswas founded Merrimack Pharmaceuticals, Inc., where he worked as President.
Dr. Biswas also currently works at VIMAC Ventures LLC, as Managing Director from 2002.
Dr. Biswas also formerly worked at Combinent BioMedical Systems, Inc., as Chairman & Chief Executive Officer, ActiveCyte, Inc., as Chief Executive Officer, Kalgene Pharmaceuticals, Inc., as Chief Executive Officer, Neotropix, Inc., as Director, Aventis Pharmaceuticals, Inc., as Director-Business Development, Angiochem, Inc., as Director, Mimetogen Pharmaceuticals, Inc., as Director, Bear, Stearns & Co., Inc., as Associate, TL Ventures, Inc., as Principal, and Lumira Capital Investment Management, Inc., as Venture Partner.
Dr. Biswas received his doctorate degree from the University of Pennsylvania, undergraduate degree from Brandeis University, and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
Cargos activos de Sena K. Biswas
Empresas | Cargo | Inicio |
---|---|---|
VIMAC Ventures LLC
VIMAC Ventures LLC Investment ManagersFinance VIMAC Ventures LLC (VIMAC Ventures) is a venture capital firm founded in 1982. The firm is headquartered in Boston, Massachusetts. | Director Ejecutivo | 01/06/2002 |
Antiguos cargos conocidos de Sena K. Biswas.
Empresas | Cargo | Fin |
---|---|---|
TL Ventures, Inc.
TL Ventures, Inc. Investment ManagersFinance TL Ventures Inc (TL Ventures) is a venture capital subsidiary of Safeguard Scientifics, Inc. founded in 1988 by Robert Keith. The firm is headquartered in Wayne, Pennsylvania. | Inversor de Capital Privado | 30/05/2002 |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Inversor de Capital Privado | - |
Kalgene Pharmaceuticals, Inc.
Kalgene Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Kalgene Pharmaceuticals, Inc. develops and focuses on personalized cancer diagnostics and drugs. It offers drugs for epithelial and thyroid cancers. The firm's oncology programs are aimed at improving clinical and survival outcomes through the use of personalized medicine, with a particular focus on bladder, epithelial and thyroid cancers. It serves the biopharmaceutical, research and development and health industries. The company is headquartered in Kingston, Canada. | Director Ejecutivo | - |
ActiveCyte, Inc. | Director Ejecutivo | - |
Mimetogen Pharmaceuticals, Inc.
Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada. | Director/Miembro de la Junta | - |
Formación de Sena K. Biswas.
University of Pennsylvania | Doctorate Degree |
Brandeis University | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 12 |
---|---|
Bear, Stearns & Co., Inc.
Bear, Stearns & Co., Inc. Investment Banks/BrokersFinance Bear, Stearns & Co., Inc. is a global investment banking, securities trading and brokerage firm located in New York City with additional offices in Dallas, Boston and San Francisco. The firm is a subsidiary Bear Sterns Cos., Inc. (NYSE: BSC). Their equity research team consists of senior analysts located throughout the world. In addition to domestic coverage, they have research teams focusing on Latin America, Asia and Europe. The analysts use a bottom-up approach to stock selection. The Bear Stearns fixed-income research department provides coverage of every sector of the fixed-income universe. The financial analytics and structured transactions group (F.A.S.T) provides investment research, fixed-income portfolio management and analytical systems, trading technology and general financial expertise. The group also provides a broad range of services to financial institutions including asset-liability management, balance sheet restructuring, receivables-based financing analysis, security and portfolio analysis, peer analysis, and historical and real-time market-based information. | Finance |
TL Ventures, Inc.
TL Ventures, Inc. Investment ManagersFinance TL Ventures Inc (TL Ventures) is a venture capital subsidiary of Safeguard Scientifics, Inc. founded in 1988 by Robert Keith. The firm is headquartered in Wayne, Pennsylvania. | Finance |
Neotropix, Inc.
Neotropix, Inc. BiotechnologyHealth Technology Neotropix, Inc. develops virus-based therapies for cancer treatment. It has developed NTX-010 virus, a small cell lung cancer treatment and as a treatment of pediatric cancers, such as neuroblastoma. The company was founded by Paul L. Hallenbeck in 2003 and is headquartered in Malvern, PA. | Health Technology |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Finance |
Merrimack Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
VIMAC Ventures LLC
VIMAC Ventures LLC Investment ManagersFinance VIMAC Ventures LLC (VIMAC Ventures) is a venture capital firm founded in 1982. The firm is headquartered in Boston, Massachusetts. | Finance |
Angiochem, Inc.
Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Health Technology |
Combinent BioMedical Systems, Inc.
Combinent BioMedical Systems, Inc. Pharmaceuticals: MajorHealth Technology Combinent BioMedical Systems, Inc. developed novel drug combinations and formulations. The company was founded by William F. Crowley, Jr. and Robert S. Langer, Jr. in 2000 and was headquartered in Lexington, MA. | Health Technology |
ActiveCyte, Inc. | |
Mimetogen Pharmaceuticals, Inc.
Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada. | Health Technology |
Kalgene Pharmaceuticals, Inc.
Kalgene Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Kalgene Pharmaceuticals, Inc. develops and focuses on personalized cancer diagnostics and drugs. It offers drugs for epithelial and thyroid cancers. The firm's oncology programs are aimed at improving clinical and survival outcomes through the use of personalized medicine, with a particular focus on bladder, epithelial and thyroid cancers. It serves the biopharmaceutical, research and development and health industries. The company is headquartered in Kingston, Canada. | Health Services |
- Bolsa de valores
- Insiders
- Sena K. Biswas